版权说明 操作指南
首页 > 成果 > 详情

hUC-MSC-EV-miR-24 enhances the protective effect of dexmedetomidine preconditioning against myocardial ischemia–reperfusion injury through the KEAP1/Nrf2/HO-1 signaling

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Hou, Zixin;Yang, Fengrui;Chen, Kemin;Wang, Yuxia;Qin, Jie;...
通讯作者:
Liang, F
作者机构:
[Qin, Jie; Liang, Feng; Liang, F; Chen, Kemin; Yang, Fengrui; Wang, Yuxia; Hou, Zixin] Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Anesthesiol, Hengyang 421001, Peoples R China.
[Yang, Fengrui] Univ South China, Affiliated Huaihua Hosp, Hengyang Med Sch, Dept Anesthesiol, Huaihua 418000, Peoples R China.
通讯机构:
[Liang, F ] U
Univ South China, Affiliated Hosp 1, Hengyang Med Sch, Dept Anesthesiol, Hengyang 421001, Peoples R China.
语种:
英文
关键词:
Dexmedetomidine;Extracellular vesicles;Human umbilical cord mesenchymal stem cells;Ischemic-reperfusion injury;KEAP1;Macrophage polarization;Nrf2/HO-1 signaling pathway;microRNA-24
期刊:
Drug Delivery and Translational Research
ISSN:
2190-393X
年:
2024
卷:
14
期:
1
页码:
143-157
基金类别:
This work was supported by the Excellent Youth Foundation of Hunan Provincial Department of Education (19B477), Project of Hunan Provincial Health Commission (20200018, 20200037), Natural Science Foundation of Hunan Province (2021JJ70043), and Guiding Project of Hengyang Science and Technology Bureau (202121034637).
机构署名:
本校为第一且通讯机构
院系归属:
医学院
摘要:
The cardioprotective effect of microRNAs (miRNAs) on myocardial ischemic-reperfusion (I/R) injury has been documented. Here, we aim to decipher the mechanism of miR-24 delivered by human umbilical cord mesenchymal stem cell-derived extracellular vesicles (hUC-MSC-EVs) in myocardial I/R injury after dexmedetomidine (DEX) preconditioning. We collected and identified hUC-MSCs and extracted EVs, which were co-cultured with DEX-preconditioned hypoxia/reoxygenation (H/R) cardiomyocyte models or injected into I/R mouse models. The cardiomyocytes and myocardial injury were evaluated by molecular biolo...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com